Based on data from the past 90 days ending February 19, 2026, Indivior Pharmaceuticals's three largest insider shareholders are Chief Financial Officer Ryan Preblick (317.94K shares), Chief Scientific Officer Christian Heidbreder (190.76K shares), Chief Executive Officer Joseph Ciaffoni (135.98K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Ryan Preblick | Chief Financial Officer | 317,940 | 12 Feb, 2026 |
| Christian Heidbreder | Chief Scientific Officer | 190,762 | 12 Feb, 2026 |
| Joseph Ciaffoni | Chief Executive Officer | 135,976 | 12 Feb, 2026 |
| Patrick A Barry | Chief Commercial Officer | 31,380 | 12 Feb, 2026 |
| Jeffrey W Burris | Chief Legal Officer | 27,657 | 12 Feb, 2026 |
| Daniel A Ninivaggi | 20,645 | 28 Jan, 2026 | |
| Mark Stejbach | 20,569 | 28 Jan, 2026 | |
| David E. Wheadon | 20,350 | 28 Jan, 2026 | |
| Woodrow D Anderson | Chief Accounting Officer | 11,293 | 12 Feb, 2026 |
| Keith Humphreys | 9,524 | 28 Jan, 2026 | |
| Juliet Thompson | 7,572 | 28 Jan, 2026 | |
| Barbara Ryan | 5,685 | 28 Jan, 2026 | |
| Stuart A Kingsley | 4,642 | 28 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 10 Feb, 2026 | Joseph Ciaffoni | Common Stock | A | 79,976 | $0.00 | 135,976 | D | A |
| 10 Feb, 2026 | Jeffrey W Burris | Common Stock | A | 26,897 | $0.00 | 27,657 | D | A |
| 10 Feb, 2026 | Patrick A Barry | Common Stock | A | 31,380 | $0.00 | 31,380 | D | A |
| 10 Feb, 2026 | Woodrow D Anderson | Common Stock | A | 6,903 | $0.00 | 11,293 | D | A |
| 10 Feb, 2026 | Christian Heidbreder | Common Stock | A | 33,622 | $0.00 | 190,762 | D | A |
| 10 Feb, 2026 | Ryan Preblick | Common Stock | A | 37,358 | $0.00 | 317,940 | D | A |
| 26 Jan, 2026 | Daniel A Ninivaggi | Common Stock | A | 3,722 | $0.00 | 20,645 | D | A |
| 26 Jan, 2026 | Stuart A Kingsley | Common Stock | A | 3,722 | $0.00 | 4,642 | D | A |
| 26 Jan, 2026 | Mark Stejbach | Common Stock | A | 3,722 | $0.00 | 20,569 | D | A |
| 26 Jan, 2026 | Juliet Thompson | Common Stock | A | 3,722 | $0.00 | 7,572 | D | A |
| 26 Jan, 2026 | David E. Wheadon | Common Stock | A | 5,955 | $0.00 | 20,350 | D | A |
| 26 Jan, 2026 | Barbara Ryan | Common Stock | A | 3,722 | $0.00 | 5,685 | D | A |
| 26 Jan, 2026 | Keith Humphreys | Common Stock | A | 3,722 | $0.00 | 9,524 | D | A |
| 05 Jan, 2026 | Daniel A Ninivaggi | Ordinary Shares | A | 775 | $35.39 | 16,923 | D | P |
| 05 Jan, 2026 | Mark Stejbach | Ordinary Shares | A | 775 | $35.39 | 16,847 | D | P |
| 05 Jan, 2026 | David E. Wheadon | Ordinary Shares | A | 1,771 | $35.39 | 14,395 | D | P |
| 05 Jan, 2026 | Barbara Ryan | Ordinary Shares | A | 775 | $35.39 | 1,963 | D | P |
| 05 Jan, 2026 | Keith Humphreys | Ordinary Shares | A | 775 | $35.39 | 5,802 | D | P |